ARC’s Fifth International Forum
The Indian pharmaceutical industry ranks high in terms of technology, quality, and range of medicines manufactured. It also has the highest number of the USFDA-approved GMP manufacturing plants outside the US. While the pharmaceutical industry enjoys low-cost production capabilities, it has to invest more in automation systems & enterprise solutions and integrate all decision-support systems to become more agile and responsive. These aspects were highlighted during ARC Advisory Group event, India’s fifth international forum, ‘Winning strategies and best practices for process industries’. Held in Hyderabad recently, this three-day forum attracted over 290 delegates, from around 90 manufacturing companies. A report
|
